Additional file 2 of Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?

Tornero, C.; Navarro-Compán, V.; Tenorio, J.; García-Carazo, S.; Buño, A.; Monjo, I.; Plasencia-Rodriguez, C.; Iturzaeta, J.; Lapunzina, P.; Heath, K.; Balsa, A.; Aguado, P.

doi:10.6084/m9.figshare.11863728.v1

13023_2020_1315_MOESM2_ESM.docx (14.35 kB)

Additional file 2 of Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?

journal contribution

posted on 2020-02-18, 05:01 authored by C. Tornero, V. Navarro-Compán, J. Tenorio, S. García-Carazo, A. Buño, I. Monjo, C. Plasencia-Rodriguez, J. Iturzaeta, P. Lapunzina, K. Heath, A. Balsa, P. Aguado

Additional file 2: Table S2. Diagnostic utility measures for each of the symptoms combined with ALP levels between 25 and 35 IU/L.

Funding

Alexion Pharmaceuticals

History

Usage metrics

Keywords

Metabolic bone diseases Hypophosphatasia Hypophosphatasaemia Alkaline phosphatase ALPL

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 2 of Can we identify individuals with an ALPL variant in adults with persistent hypophosphatasaemia?

Funding

Alexion Pharmaceuticals

History

Usage metrics

Categories

Keywords

Licence

Exports